Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

January 15, 2021

Brain 18F-FDG and 18F-Flumetamol PET Imaging of Fragile X-Associated Tremor Ataxia Syndrome

Clinical Nuclear Medicine
Ruggero BacchinStefano Tamburin
January 12, 2021
Open Access

Human Tyrosyl-DNA Phosphodiesterase 1 Possesses Transphosphooligonucleotidation Activity With Primary Alcohols

Frontiers in Cell and Developmental Biology
Nadezhda DyrkheevaOlga Lavrik
January 13, 2021

Cerebellar Ataxia as a Common Clinical Presentation Associated with DNMT1 p.Y511H and a Review of the Literature

Journal of Molecular Neuroscience : MN
Junko Kanda KikuchiShoji Tsuji
January 8, 2021

How to Do It: Microsurgical DREZotomy for Pain After Brachial Plexus Injury: 2-Dimensional Operative Video

Operative Neurosurgery
Manon DuraffourgMarc Sindou
January 1, 2021
Review
Open Access

Mirogabalin: could it be the next generation gabapentin or pregabalin?

The Korean Journal of Pain
Jae-Yeon KimKyung-Hoon Kim
January 8, 2021
Open Access

Cerebellar ataxia and exercise intolerance in Erdheim-Chester disease

Cerebellum & Ataxias
Eleonora LauricellaFrancesco Girolamo
January 11, 2021
Preprint
Open Access

Characterization of a novel variant in the HR1 domain of MFN2 in a patient with ataxia, optic atrophy and sensorineural hearing loss

BioRxiv : the Preprint Server for Biology
G. SharmaTimothy E Shutt
January 5, 2021
Preprint
Open Access

Genetic Rhabdomyolysis within the Spectrum of the Spinocerebellar Ataxia Type 2 Responsive to Pregabalin

ResearchSquare
Fabian RossiMichael Hoffmann
January 9, 2021

Expanding the clinical spectrum of STIP1 homology and U-box containing protein 1-associated ataxia

Journal of Neurology
Jean-Marie RavelMathilde Renaud
January 5, 2021
Case Report
Open Access

Development of a delayed chronic subdural hematoma 2 months after mild traumatic brain injury with a normal initial brain computed tomography: A case report

Journal of the American College of Emergency Physicians Open
Michael Yih Chong Chia
January 12, 2021
Open Access

Immune-Mediated Cerebellar Ataxias: Clinical Diagnosis and Treatment Based on Immunological and Physiological Mechanisms

Journal of Movement Disorders
Hiroshi MitomaMarios Hadjivassiliou
January 13, 2021
Review

Gabapentin add-on treatment for drug-resistant focal epilepsy

The Cochrane Database of Systematic Reviews
Mariangela PanebiancoAnthony G Marson
January 12, 2021
Review

Myoclonus-Ataxia Syndromes: A Diagnostic Approach

Movement Disorders Clinical Practice
Malco RossiBart van de Warrenburg
January 13, 2021

Deep Learning for Accelerometric Data Assessment and Ataxic Gait Monitoring

IEEE Transactions on Neural Systems and Rehabilitation Engineering : a Publication of the IEEE Engineering in Medicine and Biology Society
Ales ProchazkaOldrich Vysata
January 12, 2021
Case Report

Late-Onset Tay-Sachs Disease in an Irish Family

Movement Disorders Clinical Practice
Stela LefterAisling M Ryan

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/ataxias/4f17bd7d-f308-450f-a9e5-d6dbab2e09ae